Moderna
MRNA
#1188
Rank
A$24.24 B
Marketcap
$63.00
Share price
-0.43%
Change (1 day)
-53.03%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$24.24 Billion

As of December 2024 Moderna has a market cap of A$24.24 Billion. This makes Moderna the world's 1188th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024A$24.24 B-56.44%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Dec 21st, 2024 the market cap of Moderna was reported to be:

A$24.24 Billion
by Yahoo Finance info icon info icon
A$24.24 Billion
by CompaniesMarketCap info icon info icon
A$24.24 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.16 B-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$396.70 B 1,536.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.33 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.63 B 108.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$310.52 B 1,180.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.87 B-84.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$556.31 B 2,194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.76 B-80.36%๐Ÿ‡บ๐Ÿ‡ธ USA